Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner ...

Topline results were announced from two phase 3 trials evaluating itepekimab, an anti-interleukin-33 monoclonal antibody, in former smokers with inadequately controlled chronic obstructive pulmonary ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation.

The partnership is poised to increase patient impact, especially for those who would benefit from enhanced care co-ordination ...

All guidelines state that COPD is indeed a treatable disease, so that’s the word we want to get across. Dr. Yamo Deniz Unfortunately, our healthcare systems are currently not recognizing unmet ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

Remember, COPD treatment is a long-term journey with ... within a certain amount of time — one hour is a common guideline — intubation and mechanical ventilation is the next treatment offered.

Samuel Louie; Amir A Zeki; Michael Schivo; Andrew L Chan; Ken Y Yoneda; Mark Avdalovic; Brian M Morrissey; Timothy E Albertson The Spanish COPD guidelines propose four COPD phenotypes that ...

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.